Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - December 2013

Advances in Electrophysiology Europe, 2013 – A Spotlight on Ion Channel Research – Highlighting Automated Physiology

10 Dec 2013 - 10 Dec 2013 - Saffron Walden, Cambridge, UK

Bookmark and Share

Advances in drug discovery technologies now allow ion channels to be significantly more promising targets for drug discovery. This meeting has been structured to focus on recent developments in patch clamp, which have revolutionised the use of electrophysiology as a tool for drug discovery and functional screening. An authoritative panel of experienced pharmaceutical industry scientists and academics has been assembled for this meeting that will have a special emphasis upon automated electrophysiology.

Professor David Brown, UCL, UK and Dr Edward Stevens, Pfizer Neusentis, UK will give the keynote presentations. Professor David Brown will discuss his far-reaching research into the regulation of ion channels that control neural excitability, with a special emphasis on his work with the Kv7 potassium channel. Drawing upon his extensive knowledge of the drug discovery industry both in CRO’s and pharmaceutical companies, Dr Edward Stevens will review the contribution that automated electrophysiology is making to drug discovery and development.

Speakers will then discuss the development and potential of these new technologies, present experimental results obtained with these systems and debate the potential impact of current technologies and future developments.

These presentations will include data from platforms including the IonWorks Barracuda®, IonWorks® Quattro™, PatchXpress® and IonFlux™ instrumentation:

  • Matthew Bridgland-Taylor, AstraZeneca, UK - Exploitation of the IonWorks Barracuda Automated Electrophysiology Platform to Improve Assessment of Cardiac Liability
  • Kelly Gatfield, GlaxoSmithKline, UK - Development of IonWorks Barracuda assays for use in early stage safety profiling
  • Gary Clarke, BioFocus DPI, UK - Ion Channel Drug Discovery: Case Study Utilising Automated Electrophysiology
  • Mark McPate, Novartis, UK - Investigation of the TRPC Channel using the IonWorks Quattro
  • Oliver Leven, GeneData, Switzerland - Genedata Screener for Automated Patch Clamping

Further information
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
NIH Supports New Studies to Find Alzheimer’s Biomarkers in Down Syndrome
Initiative will track dementia onset, progress in Down syndrome volunteers.
University of Edinburgh, Selcia Achieve Key Milestones in Drug Development Program
Scientists from the University of Edinburgh, working with Selcia, have successfully passed the 20-month milestone targets of a 30-month Wellcome Trust SDDi £2.5 million project to design novel treatments for sleeping sickness.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
World’s First Therapeutic Venom Database
Open-source library describes nearly 43,000 effects on the human body.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
The Do’s and Don’ts of SPR Experiments
Surface Plasmon Resonance (SPR) is a technique that is becoming more widely used, particularly by anyone who wants to obtain accurate on (association) and off (dissociation) rates for biomolecular binding.
Long-Sought Protein Sensor for the ‘Sixth Sense’ Discovered
In a study led by scientists from The Scripps Research Institute (TSRI)the sensor protein for propioception has been identified.
Scroll Up
Scroll Down

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos